Back to AMRN Stock Lookup

Amarin Corp plc (AMRN) – Press Releases

May 8, 2015 06:00 AM Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations
May 5, 2015 05:00 PM Amarin to Report First Quarter 2015 Results and Host Conference Call on May 8, 2015
Apr 8, 2015 08:00 AM Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts
Mar 16, 2015 04:30 PM New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other
Mar 6, 2015 05:00 AM Amarin Announces $52.8 Million Private Placement
Mar 4, 2015 08:00 AM New In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit
Mar 3, 2015 04:00 PM Amarin Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Update on Operations
Feb 26, 2015 09:16 AM Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl) in China
Feb 23, 2015 04:30 PM Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015
Dec 15, 2014 07:10 AM Annual Changes to the NASDAQ Biotechnology Index
May 15, 2014 05:00 AM Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes
May 9, 2014 07:00 AM Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations
Mar 31, 2014 04:30 PM Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules
Feb 27, 2014 04:01 PM Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations
Feb 21, 2014 04:01 PM Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules
Feb 6, 2014 06:30 AM Amarin to Present at the 2014 Leerink Global Healthcare Conference
Feb 4, 2014 06:00 AM Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Jan 15, 2014 04:05 PM Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed
Dec 20, 2013 06:00 AM Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed
Dec 16, 2013 09:00 AM Amarin Announces Leadership Changes

Back to AMRN Stock Lookup